276 related articles for article (PubMed ID: 24584596)
1. Metformin in peritoneal dialysis: a pilot experience.
Al-Hwiesh AK; Abdul-Rahman IS; El-Deen MA; Larbi E; Divino-Filho JC; Al-Mohanna FA; Gupta KL
Perit Dial Int; 2014 Jun; 34(4):368-75. PubMed ID: 24584596
[TBL] [Abstract][Full Text] [Related]
2. The Phantom of Metformin-Induced Lactic Acidosis in End-Stage Renal Disease Patients: Time to Reconsider with Peritoneal Dialysis Treatment.
Al-Hwiesh AK; Abdul-Rahman IS; Noor AS; Nasr-El-Deen MA; Abdelrahman A; El-Salamoni TS; Al-Muhanna FA; Al-Otaibi K; Al-Audah N
Perit Dial Int; 2017 1-2; 37(1):56-62. PubMed ID: 27680758
[TBL] [Abstract][Full Text] [Related]
3. Occult metformin toxicity in three patients with profound lactic acidosis.
Perrone J; Phillips C; Gaieski D
J Emerg Med; 2011 Mar; 40(3):271-5. PubMed ID: 18571361
[TBL] [Abstract][Full Text] [Related]
4. Lactic acidosis due to metformin in type 2 diabetes mellitus and chronic kidney disease stage 3-5: is it significant?
Prabhu RA; Mareddy AS; Nagaraju SP; Rangaswamy D; Guddattu V
Int Urol Nephrol; 2019 Jul; 51(7):1229-1230. PubMed ID: 30963454
[TBL] [Abstract][Full Text] [Related]
5. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
[TBL] [Abstract][Full Text] [Related]
6. Association between Metformin Use and Risk of Lactic Acidosis or Elevated Lactate Concentration in Type 2 Diabetes.
Lee EY; Hwang S; Lee YH; Lee SH; Lee YM; Kang HP; Han E; Lee W; Lee BW; Kang ES; Cha BS; Lee HC
Yonsei Med J; 2017 Mar; 58(2):312-318. PubMed ID: 28120561
[TBL] [Abstract][Full Text] [Related]
7. [Metformin-associated lactic acidosis precipitated by acute renal failure].
Pertek JP; Vidal S; Mariot J; Galy-Floc'h M; Azoulay E
Ann Fr Anesth Reanim; 2003 May; 22(5):457-60. PubMed ID: 12831972
[TBL] [Abstract][Full Text] [Related]
8. Lactate levels and risk of lactic acidosis with metformin in diabetic kidney disease patients.
Bipi PK; George J; Gomathy S; Gracious N; Kumar S; Mohandas MK
Saudi J Kidney Dis Transpl; 2017; 28(6):1356-1361. PubMed ID: 29265047
[TBL] [Abstract][Full Text] [Related]
9. Risk of Metformin-Associated Lactic Acidosis (MALA) in Patients After Gastric Bypass Surgery.
Deden LN; Aarts EO; Aelfers SCW; van Borren MMGJ; Janssen IMC; Berends FJ; de Boer H
Obes Surg; 2018 Apr; 28(4):1080-1085. PubMed ID: 29058235
[TBL] [Abstract][Full Text] [Related]
10. Peritoneal dialysis treatment of metformin-associated lactic acidosis in a diabetic nephropathy patient
.
Gao J; Gu Z; Xu Y; Na Y
Clin Nephrol; 2016 Nov; 86 (2016)(11):279-282. PubMed ID: 27509590
[TBL] [Abstract][Full Text] [Related]
11. Survival after metformin-associated lactic acidosis in peritoneal dialysis--dependent renal failure.
Schmidt R; Horn E; Richards J; Stamatakis M
Am J Med; 1997 May; 102(5):486-8. PubMed ID: 9217647
[No Abstract] [Full Text] [Related]
12. Metformin-associated lactic acidosis in a peritoneal dialysis patient.
Almaleki N; Ashraf M; Hussein MM; Mohiuddin SA
Saudi J Kidney Dis Transpl; 2015 Mar; 26(2):325-8. PubMed ID: 25758883
[TBL] [Abstract][Full Text] [Related]
13. Safety of metformin in patients with chronic obstructive pulmonary disease and type 2 diabetes mellitus.
Hitchings AW; Archer JR; Srivastava SA; Baker EH
COPD; 2015 Apr; 12(2):126-31. PubMed ID: 25938184
[TBL] [Abstract][Full Text] [Related]
14. Lactic acidosis in metformin-treated patients. Prognostic value of arterial lactate levels and plasma metformin concentrations.
Lalau JD; Race JM
Drug Saf; 1999 Apr; 20(4):377-84. PubMed ID: 10230584
[TBL] [Abstract][Full Text] [Related]
15. Metformin-Associated Lactic Acidosis-Is This on Your Radar?
Simon EL; Sherry AC; Rabinowitz J
J Emerg Med; 2024 Apr; 66(4):e530-e533. PubMed ID: 38423865
[TBL] [Abstract][Full Text] [Related]
16. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.
Salpeter SR; Greyber E; Pasternak GA; Salpeter EE
Cochrane Database Syst Rev; 2010 Apr; 2010(4):CD002967. PubMed ID: 20393934
[TBL] [Abstract][Full Text] [Related]
17. Safety of Metformin Therapy in Patients with Type 2 Diabetes Living on an Oxygen-Deficient Plateau, Tibet, China.
Lv X; Ren Q; Zhou L; Geng Y; Song J; Mina A; Puchi B; Yang S; Meng S; Yang L
Exp Clin Endocrinol Diabetes; 2018 Jul; 126(7):460-464. PubMed ID: 29117615
[TBL] [Abstract][Full Text] [Related]
18. Risk of lactic acidosis or elevated lactate concentrations in metformin users with renal impairment: a population-based cohort study.
Eppenga WL; Lalmohamed A; Geerts AF; Derijks HJ; Wensing M; Egberts A; De Smet PA; de Vries F
Diabetes Care; 2014 Aug; 37(8):2218-24. PubMed ID: 24842984
[TBL] [Abstract][Full Text] [Related]
19. Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparison.
Wang JS; Lin SD; Lee WJ; Su SL; Lee IT; Tu ST; Tseng YH; Lin SY; Sheu WH
Clin Ther; 2011 Dec; 33(12):1932-42. PubMed ID: 22078152
[TBL] [Abstract][Full Text] [Related]
20. A justification for less restrictive guidelines on the use of metformin in stable chronic renal failure.
Adam WR; O'Brien RC
Diabet Med; 2014 Sep; 31(9):1032-8. PubMed ID: 24909998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
